Oragenics' oral care probiotics for children and adults will be available in Australia and New Zealand through an exclusive agreement with Australian Pharmaceutical Industries (API), owner of the Priceline pharmacy retail chain.
This agreement brings Oragenics' ProBiora3 oral care probiotics, patented in Australia and New Zealand, to the region. The products include EvoraPlus, a probiotic mint for adults that supports gum and tooth health, freshens breath gently, and naturally whitens teeth; and EvoraKids, formulated to address the dental needs of children ages 3 to 10.
This partnership will help Oragenics expedite its entry into the Australian and New Zealand markets and is expected to accelerate the registration process of its oral care probiotics in these countries, according to the company.
.RbyOLNR6ps.png?crop=focalpoint&fit=crop&fp-x=0.5&fp-y=0.5&h=100&w=100&auto=format%2Ccompress&q=70)
.hpp4JFpXkV.png?crop=focalpoint&fit=crop&fp-x=0.5&fp-y=0.5&h=167&w=250&auto=format%2Ccompress&q=70)
